CHARLES SCHWAB INVESTMENT MANAGEMENT INC - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 62 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2018. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q1 2019$95,000
-60.9%
74,9200.0%0.00%
Q4 2018$243,000
+113.2%
74,920
+59.7%
0.00%
Q3 2018$114,000
-13.0%
46,9000.0%0.00%
Q2 2018$131,000
+50.6%
46,900
+156.3%
0.00%
Q1 2018$87,000
-18.7%
18,3000.0%0.00%
Q4 2017$107,000
+174.4%
18,3000.0%0.00%
Q3 2017$39,000
-54.7%
18,3000.0%0.00%
Q2 2017$86,000
-61.3%
18,300
-35.3%
0.00%
Q1 2017$222,000
-36.0%
28,3000.0%0.00%
Q4 2016$347,000
+122.4%
28,300
+183.0%
0.00%
Q3 2016$156,000
+27.9%
10,0000.0%0.00%
Q2 2016$122,00010,0000.00%
Other shareholders

There were no reported owners of PROTEOSTASIS THERAPEUTICS IN in Q2 2018.

NameSharesValueWeighting ↓
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders